Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves

Over the past six months, Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) is also up over 100%, and up 17.06% year-to-date. Much of that recent rise came after the company released its preliminary fiscal 2014 fourth quarter results on January 13, which came in above the consensus estimates. Zeltiq expects fourth quarter revenue of $51 to $52 million, and full-year revenue of $175 to $176 million. Analysts are just as bullish on Zeltiq Aesthetics Inc (NASDAQ:ZLTQ), which is best known for its CoolSculpting system, a non-invasive system which targets and reduces fat. Zacks recently upgraded Zeltiq to a “Buy” rating, while Maxim Group raised their price target on the stock from to $39.00 from $33.00.

Zeltiq also has quite a bit of insider trading activity of late, though on the contrary to Five Prime, their activity has involved sales. Six different Zeltiq insiders have made sales during 2015, with over 100,000 insiders’ shares being sold in total. In fact it was strong insider selling activity in the days leading up to the January 13 earnings report that were partially responsible for the stock price dropping under $27.00 at one point, before rising back up over $29.00 by the close on January 14.

Other funds we track with positions in Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) include Dennis Purcell’s Aisling Capital with 2.58 million shares, Sean Cullinan’s Point State Capital with 1.60 million shares, and Ricky Sandler’s Eminence Capital with 1.24 million shares.

Disclosure: None